Hormos Medical Ltd
+358 (0)40 310 8000
chemistry (at) hormos.com, administration (at) hormos.com
Hormos Medical Ltd is a drug development company in Turku and Oulu. Its core competence is focused on the novel selective drugs based on the sex hormone mechanism. The first invention, Osfena for the treatment of menopausal symptoms, is at the regulatory approvals phase with the licensee Shionogi. Fispemifene, for the male hypogonadism, is in clinical development and a novel tissue specific drug is entering clinical studies in endometriosis and breast cancer.